Last reviewed · How we verify
Two doses of quadrivalent influenza vaccine
Two doses of quadrivalent influenza vaccine is a Biologic drug developed by Sinovac Biotech Co., Ltd. It is currently FDA-approved.
At a glance
| Generic name | Two doses of quadrivalent influenza vaccine |
|---|---|
| Sponsor | Sinovac Biotech Co., Ltd |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate the Safety and Immunogenicity of Two Doses of DCVC H1 HA mRNA-LNP in Healthy Adults (PHASE1)
- Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae (PHASE2)
- High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients (PHASE2)
- Systems Biological Assessment of Statin Effect on Vaccine Responses (PHASE4)
- A Clinical Trial of an Quadrivalent Influenza Virus Subunit Vaccine in Chinese Children Aged 6 to 35 Months (PHASE3)
- High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients (PHASE2)
- Randomized Influenza Vaccine Evaluation of Immune Response (PHASE4)
- A Study to Evaluate the Safety and Immunogenicity of a Single Dose of H1ssF-3928 mRNA-LNP in Healthy Adults (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Two doses of quadrivalent influenza vaccine CI brief — competitive landscape report
- Two doses of quadrivalent influenza vaccine updates RSS · CI watch RSS
- Sinovac Biotech Co., Ltd portfolio CI
Frequently asked questions about Two doses of quadrivalent influenza vaccine
What is Two doses of quadrivalent influenza vaccine?
Two doses of quadrivalent influenza vaccine is a Biologic drug developed by Sinovac Biotech Co., Ltd.
Who makes Two doses of quadrivalent influenza vaccine?
Two doses of quadrivalent influenza vaccine is developed and marketed by Sinovac Biotech Co., Ltd (see full Sinovac Biotech Co., Ltd pipeline at /company/sinovac-biotech-co-ltd).
What development phase is Two doses of quadrivalent influenza vaccine in?
Two doses of quadrivalent influenza vaccine is FDA-approved (marketed).